Trial
NCT02106572
Therapeutic Instillation of Mistletoe
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Abnoba Gmbh
Collaborators
—
Condition
Superficial Bladder Cancer
Intervention
abnobaVISCUM 900
Why stopped
The study was terminated because the required number of patients cannot be reached in the foreseeable future. Recruitment was not stopped due to safety issues. Follow-up for all patients was completed according protocol including safety monitoring.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-22